Flosonics Medical was founded with the mission of providing clinicians the hemodynamic information they need to make better decisions at the point-of-care. With deep domain expertise, Flosonics saw the need for a non-invasive and wearable sensor which could better serve clinicians and patients via patient monitoring in the fields of cardiology, respiratory and critical care medicine. The FloPatch is the first wearable sensor to comply with the updated 2016 Surviving Sepsis Guidelines. Flosonics Medical has developed the world’s first disposable ultrasound patch. FloPatch™ is the only rapid, non-invasive hemodynamic monitor that can help clinicians titrate-to-effect in vulnerable patients. FloPatch requires little-to-no training, and provides real-time monitoring in the hospital or remotely for EMS or community care.